). To determine coinduced with SREBP1c/1a in response to short-term high-fat feeding of mice. PGC-1␤ coactivates the SREBP whether dietary fats have a direct impact on PGC-1␤ expression, we treated primary hepatocytes with variand LXR families of transcription factors as it induces a broad program of lipid metabolism, including de novo ous saturated, unsaturated, and trans fatty acids and examined the levels of PGC-1␤ mRNA. While monounlipogenesis and lipoprotein secretion. Our studies reveal a novel mechanism whereby consumption of saturated saturated (oleic acid, C 18:1 n-9) and polyunsaturated (linoleic acid, C 18:2 n-6; EPA, C 20:5 n-3; DHA, C 22:6 n-3; and arafats may alter hepatic lipid metabolism and lead to hypertriglyceridemia and hypercholesterolemia. chidonic acid, C 20:4 n-6) slightly induce PGC-1␤ expression, saturated fatty acids of varying chain length (C 10:0 to C 18:0 ) elevate PGC-1␤ mRNA levels much more Results strongly ( Figure 1C ). Strikingly, trans fatty acids such as elaidic acid (trans-C 18:1 n-9) and trans-vaccenic acid
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(trans-C 18:1 n-7), abundantly present in hydrogenated by High-Fat Feeding vegetable oil and dairy products, respectively, also roMetabolic pathways leading to increased total and LDL bustly induce the expression of PGC-1␤ (3.2-fold). In cholesterol from consumption of saturated and trans contrast, fatty acid treatments have no effect on the fats are incompletely understood. To investigate this, expression of PGC-1␣ mRNA under these conditions, we fed mice a diet rich in saturated fats but with little except stearic acid (C 18:0 ), which also induces PGC-1␣ or no cholesterol (58% fat, mainly from hydrogenated mRNA 2.2-fold ( Figure 1C ). These results indicate that coconut oil; D12331, Research Diets). We concentrated certain fatty acids, especially saturated and trans speon early changes, as these diets are known to bring cies, can stimulate PGC-1␤ expression in a cell-autonoabout many chronic effects, such as insulin resistance mous manner. and obesity, which may confound the study of regulatory events leading to hyperlipidemia. Clustering analysis of Affymetrix arrays revealed that the expression of a large Coactivation of the SREBP Family of Transcription Factors by PGC-1␤ number of genes involved in de novo lipid synthesis are strongly induced following this high-fat feeding, includCoinduction of PGC-1␤ and SREBP1c in the liver of highfat-fed mice suggested that PGC-1␤ might modulate ing those responsible for fatty acid, cholesterol, and tri- ( Figure 2D ). In order to identify domains of PGC-1␤ that interact with SREBP1c, we utilized a fusion protein beMutation of the SREBP binding site on the promoter completely abolishes its activation by both SREBP1c tween GST and the processed form of SREBP1c. Fulllength PGC-1␤ interacts well with SREBP1c ( Figure 2E ), alone and the combination of SREBP1c and PGC-1␤, indicating that PGC-1␤ coactivates SREBP1c through and analysis of PGC-1␤ mutants revealed that a domain (amino acids 350-530) unique for PGC-1␤, but absent the SRE on this promoter. PGC-1␤ also strongly increases the activity of SREBP2 and SREBP1a in these in PGC-1␣, is required for interaction between SREBP1c and PGC-1␤ ( Figures 2E-2F ). These data indicate that coactivation assays ( Figure 2B and data not shown).
To determine whether PGC-1␤ is recruited to SREs PGC-1␤, but not PGC-1␣, coactivates the SREBP family of transcription factors by direct physical association. present in the promoter/enhancer region of endogenous SREBP target genes, we performed chromatin immunoprecipitation (ChIP) assay. As shown in Figure 2C (Figures 5C and 5D) . Furthermore, these two coactivators
The fact that PGC-1␤ is highly induced along with SREBP1a/1c in response to high-fat feeding suggests are able to directly bind LXR␣ in an in vitro interaction assay ( Figure 5E ). Deletion of a small region that conthat the concentration of PGC-1␤ in hepatocytes may be a necessary and limiting factor for SREBP activity. To tains the conserved LXXLL motif (PGC-1␤ N350) reduced the binding between PGC-1␤ and LXR and comexamine this possibility, we constructed RNAi vectors (RNAi #1 and #2) that specifically knock down PGC-1␤ pletely abolished the effects of ligand. Figure 6C and data not shown). Importantly, these PGC-1␤ RNAi vecas SCD-1 (3.5-fold), FAS (3.6-fold), and HMG-CoA reductase (1.8-fold). The induction of all these genes in tors have little or no effect on the regulation of G6Pase promoter activity by PGC-1␣ and HNF4␣ ( Figure 6D) . response to SREBP1c, however, is greatly impaired in the cells infected with Ad-RNAi compared to the control These RNAi vectors also do not alter LXR␣/RXR␤ transcriptional activity when assayed on a reporter con-GFP. Notably, while the induction of FAS and HMG-CoA reductase is decreased more than 50%, the expression taining multimerized LXR responsive elements ( Figure  6E ), perhaps due to the presence of PGC-1␣ and/or of SCD-1 mRNA is reduced to near the basal level even in the presence of SREBP1c. In contrast, the induction other coactivator proteins for LXRs in hepatocytes. of LXR target genes, such as SREBP1c, is not affected Surprisingly, the mRNA level of LDLR is also reduced by approximately 40% in response to PGC-1␤ knockdown, by PGC-1␤ knockdown ( Figure 6H) , perhaps reflecting the observation that PGC-1␣ is also capable of coactisuggesting that this coactivator may be a limiting factor, directly or indirectly, for optimal expression of LDLR in vating LXR and stimulating the expression of its targets (Figure 5) . the liver. These data clearly illustrate that PGC-1␤ is indeed necessary for the full activation of the lipogenic To examine whether PGC-1␤ is required for the activation of lipogenic gene expression in vivo, especially in program by the SREBPs and perhaps other as yet undefined transcription factors in the mouse liver. the context of high-fat feeding, we transduced mice with Ad-RNAi directed against PGC-1␤ or a control random Consistent with a key role of PGC-1␤ in the regulation of lipoprotein synthesis and secretion, plasma triglycerRNAi for four days and then switched animals to a highfat diet for two days. As expected, the Ad-RNAi directed ide concentration is significantly reduced (15%) in AdRNAi-transduced mice when fed either chow or a highagainst PGC-1␤ greatly reduced endogenous PGC-1␤ protein in the liver ( Figure 7A ). Analysis of hepatic gene fat diet ( Figure 7C ). Hepatic triglyceride levels tend to be higher in the RNAi group, but the difference does expression indicates that the mRNA level of several key lipogenic enzymes, including FAS, SCD-1, and HMGnot reach statistical significance. As expected, plasma cholesterol level is increased in mice following high-fat CoA reductase, is significantly decreased in the liver from mice receiving Ad-RNAi compared to the control feeding ( Figure 7D ). Somewhat surprisingly, total plasma cholesterol concentration is slightly but significantly RNAi vector ( Figure 7B ). The expression of CYP7a1, PLTP, and PGC-1␣ is similar between the two groups.
higher in Ad-RNAi-transduced mice following high fat feeding. This is due to an increase in both HDL and nona significant decrease in the expression of mRNA for the LDLR ( Figure 7B ). These data suggest that PGC-1␤ HDL cholesterol ( Figure 7D ). This could be due, at least is indeed involved in control of the LDLR promoter and in part, to the decreased expression of LDLR observed that suppression of hepatic LDLR expression may play when PGC-1␤ is knocked down in live animals ( following Ad-SREBP1c infection and analyzed by real-time PCR. Liver triglycerides were extracted using chloroform/methanol (2:1) Adenoviral transduction in mice was performed by tail vein injecmix, dried in fume hood overnight, and dissolved in a solution contion at 1.5 ϫ 10 11 viral particles per mouse (three-month-old C57Bl/ taining 60% butanol and 40% of the Triton-X114/methanol mix (2:1). 6 males). After four days, the animals were switched to a high-fat Liver and plasma triglyceride concentrations were measured using diet for two more days. Plasma samples were collected before and a colorimetric assay kit (337, Sigma). Total plasma cholesterol was after high-fat feeding and assayed for triglyceride and cholesterol determined using the Infinity cholesterol reagent (401, Sigma). For concentrations. HDL cholesterol was measured using an automated lipoprotein analysis, 300 l of plasma was fractionated by FPLC.
ACE Clinical Chemistry System (ALFA Wassermann, New Jersey).
Concentrations of triglycerides and cholesterol in each fraction were
Liver was dissected at the end of high-fat feeding for gene expresdetermined as described above. Data represent mean Ϯ SEM. sion and lipid analysis.
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